Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FST-201 vs. Ciprodex in acute otitis externa
NCT00961675Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of FST-201 in acute otitis externa (AOE), sponsored by Takeda. Started Aug 2009; status: completed.
02
Drugs
FST-201
03
Conditions
acute otitis externa (AOE)
Beyond the preview
Go deeper on NCT00961675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961675.